Sucantis Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.00 Cr
- Revenue Growth %
- Ebitda
- Net Worth 400.00%
- Total Assets 58614.68%
About Sucantis Biotech
Sucantis Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 2021 (Three years and two months 18 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹42.00 Cr.
Dilip Tiwari, Dhirendra Tiwari, and Ankur Tiwari serve as directors at the Company.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299HR2021PTC099275
-
Company No.
099275
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Nov 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Sucantis Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Tiwari
|
Director | 17-Nov-2021 | Current |
|
Dhirendra Tiwari
|
Director | 09-Jun-2022 | Current |
|
Ankur Tiwari
|
Director | 17-Nov-2021 | Current |
Financial Performance of Sucantis Biotech.
Sucantis Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 400%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sucantis Biotech?
In 2023, Sucantis Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sucantis Healthcare Private LimitedDilip Tiwari is a mutual person
-
Capsules Centre Private Limited
Dilip Tiwari is a mutual person
-
Prj Print And Pack Private Limited
Dilip Tiwari is a mutual person
-
Sencare Life Sciences Private Limited
Dilip Tiwari is a mutual person
-
Eutropia Laboratories Private Limited
Dilip Tiwari is a mutual person
-
Tiwari Pharma Private Limited
Dilip Tiwari and Dhirendra Tiwari are mutual person
Charges (Loans)
₹42.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 42.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2023 | Hdfc Bank Limited | ₹42.00 Cr | Open |
How Many Employees Work at Sucantis Biotech?
Sucantis Biotech has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sucantis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sucantis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.